Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial (Q38419469)
Jump to navigation
Jump to search
scientific article published on 06 December 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial |
scientific article published on 06 December 2014 |
Statements
1 reference
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial (English)
1 reference
Becky Schweighardt
1 reference
Troy Tompkins
1 reference
Kelly Lau
1 reference
Lynne Jesaitis
1 reference
Yulan Qi
1 reference
Donald G Musson
1 reference
Pamela Farmer
1 reference
Christine Haller
1 reference
Adam J Shaywitz
1 reference
Ke Yang
1 reference
Charles A O'Neill
1 reference
6 December 2014
1 reference
1 reference
Identifiers
1 reference